Next-generation anti-obesity drugs: emerging molecular targets and translational opportunities
Authors:
- Sneha ShettySSSneha Shetty
- Asmi RangleARAsmi Rangle
- Anirban Goutam MukherjeeAnirban Goutam Mukherjee
- Ankit Kumar BhartiABAnkit Kumar Bharti
- Sudip Prasad JenaSJSudip Prasad Jena
- Sabina Evan PrinceSPSabina Evan Prince
- Abilash Valsala GopalakrishnanAbilash Valsala Gopalakrishnan
- 19 November 2026
- journal article
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 26 (1)
Abstract
No abstract availableFunding Information
- VIT University (SG20250049)
This publication has 231 references indexed in Scilit:
- Novel Amylin‐Based Therapies for Weight Management in Adults With Overweight or Obesity Without Diabetes: A Network Meta‐AnalysisEndocrinology, Diabetes & Metabolism, 2026
- GLP‐1 at the Metabolic–Cognitive Interface: Reward, Affect, and MemoryComprehensive Physiology, 2026
- Topiramate Enhances GABAergic Tone to Orexigenic Neuropeptide Y/Agouti‐Related Peptide ( NPY / AgRP ) NeuronsObesity, 2025
- Obesity‐ and diet‐induced plasticity in systems that control eating and energy balanceObesity, 2024
- Epigenetic modifications in obesity‐associated diseasesMedcomm, 2024
- AMP‐activated protein kinase is a key regulator of obesity‐associated factorsCell Biochemistry and Function, 2022
- Weight loss between glucagon‐like peptide‐1 receptor agonists and bariatric surgery in adults with obesity: A systematic review and meta‐analysisObesity, 2022
- Pegbelfermin (BMS‐986036), PEGylated FGF21, in Patients with Obesity and Type 2 Diabetes: Results from a Randomized Phase 2 StudyObesity, 2018
- Triglyceride Metabolism in the Liver2017
- Spexin is a novel human peptide that reduces adipocyte uptake of long chain fatty acids and causes weight loss in rodents with diet‐induced obesityObesity, 2014